1. Histone Deacetylase Inhibitors in Medical Therapeutics
   P. Chun, 2016, Medical Epigenetics CrossRef
2. Differences in Reperfusion-Induced Mitochondrial Oxidative Stress and Cell Death Between Hippocampal CA1 and CA3 Subfields Are Due to the Mitochondrial Thioredoxin System
   Bocheng Yin et al, 2017, Antioxidants & Redox Signaling CrossRef
3. A novel HDAC6 inhibitor exerts an anti-cancer effect by triggering cell cycle arrest and apoptosis in gastric cancer
   Jing Dong et al, 2018, European Journal of Pharmacology CrossRef
4. The role of thioredoxin system in cancer: strategy for cancer therapy
   Jin-Jing Jia et al, 2019, Cancer Chemotherapy and Pharmacology CrossRef
5. Synthesis and Anticancer Potential of New Hydroxamic Acid Derivatives as Chemotherapeutic Agents
   Işıl Nihan Korkmaz et al, 2022, Applied Biochemistry and Biotechnology CrossRef
6. Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus
   Natália Lourenço de Freitas et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
7. Suberoylanilide Hydroxamic Acid, an Inhibitor of Histone Deacetylase, Induces Apoptosis in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
   Hui Chen et al, 2016, Inflammation CrossRef
8. The in vitro and vivo anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) and MG132 on the aggressive phenotypes of gastric cancer cells
   Hang Lu et al, 2016, Oncotarget CrossRef
9. The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy
   Iason Psilopatis et al, 2023, Cancers CrossRef
10. Histone deacetylase inhibitors in medical therapeutics
    P. Chun, 2021, Medical Epigenetics CrossRef
11. Real-Time Search-Assisted Multiplexed Quantitative Proteomics Reveals System-Wide Translational Regulation of Non-Canonical Short Open Reading Frames
    Hiroko Kozuka-Hata et al, 2023, Biomolecules CrossRef
12. Upregulated thioredoxin and its reductase prevent H2O2-induced growth inhibition and death in human pulmonary artery smooth muscle cells
    Woo Hyun Park, 2019, Toxicology in Vitro CrossRef
13. Metabolic changes in rat serum after administration of suberoylanilide hydroxamic acid and discriminated by SVM
    J Yu et al, 2017, Human & Experimental Toxicology CrossRef
14. Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers
    Nelly M. Dabbour et al, 2022, Journal of Drug Delivery Science and Technology CrossRef
15. ING5‐mediated antineuroblastoma effects of suberoylanilide hydroxamic acid
    Ji‐cheng Wu et al, 2018, Cancer Medicine CrossRef
16. Vorinostat (SAHA) May Exert Its Antidepressant-Like Effects Through the Modulation of Oxidative Stress Pathways
    Paulina Misztak et al, 2021, Neurotoxicity Research CrossRef
17. Suberoylanilide hydroxamic acid induces thioredoxin1‐mediated apoptosis in lung cancer cells via up‐regulation of miR‐129‐5p
    Bo Ra You et al, 2017, Molecular Carcinogenesis CrossRef
18. Thiol antioxidant thioredoxin reductase: A prospective biochemical crossroads between anticancer and antiparasitic treatments of the modern era
    Nikhilesh Joardar et al, 2020, International Journal of Biological Macromolecules CrossRef
19. Fucoidan induces ROS-dependent epigenetic modulation in cervical cancer HeLa cell
    Saad Mustafa et al, 2021, International Journal of Biological Macromolecules CrossRef